FBLN1 and urinary bladder carcinoma: FBLN1, a glycoprotein member of ECM, is epigenetically downregulated in bladder cancer [40] and interacts with ADAMTS to reduce the proliferation of the breast cancer cell lines MCF7 and MDA-MB-231.